Previous Close | 3.12 |
1-Year Change | -42.22% |
6-Months Change | -33.48% |
3-Months Change | 22.35% |
Moving Avg (50d) | 3.3814 |
Moving Avg (200d) | 4.04 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 114.8M |
Beta (3-Years) | 2.04 |
Revenue Growth (ttm) | % |
Net Profit Margin (ttm) | % |
Return On Assets (ttm) | -67.24% |
EPS (ttm) | -1.23 |
PE Ratio (ttm) | -2.54 |
Dividend Yield | % |
Asset Description: | PDS Biotechnology Corporation |
Predicted Direction: | Buy |
Signal Strength: | Buy |
Forecast Date: | 2024-09-10 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
3.058 | 2.964 | 2.902 | 2.808 | 2.652 | 2.496 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.